Current Hypertension Reports

, Volume 3, Issue 3, pp 216–224

New trends in the treatment of orthostatic hypotension

  • Jens Jordan


Nonpharmacologic and pharmacologic treatment can significantly attenuate the symptoms of orthostatic hypotension. Some of the interventions that are used to treat orthostatic hypotension have been known for decades. However, several new treatment strategies have been developed in recent years. New knowledge about the pathophysiology of orthostatic syndromes has been gathered that will strongly influence the way treatments are tailored to individual patients. For example, patients with and without residual autonomic function exhibit differential responses to certain treatments. A large subgroup of patients with severe autonomic failure show a profound pressor response to water drinking. This simple effect can be exploited to treat orthostatic and postprandial hypotension in some patients. New bioengineering technologies that attempt to replicate normal baroreflex mechanisms may become available for selected patients with central autonomic dysfunction.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Robertson D: Treatment of cardiovascular disorders: orthostatic hypotension. In Clinical Pharmacology Basic Principles in Therapeutics. Edited by Melmon KL, Morrelli HF. New York: McGraw-Hill; 1992:84–103.Google Scholar
  2. 2.
    Onrot J, Goldberg MR, Hollister AS, et al.: Management of chronic orthostatic hypotension. Am J Med 1986, 80:454–464.PubMedCrossRefGoogle Scholar
  3. 3.
    Biaggioni I, Robertson RM, Robertson D: Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol 1994, 34:418–423.PubMedGoogle Scholar
  4. 4.
    Shannon JR, Jordan J, Diedrich A, et al.: Sympathetically mediated hypertension in autonomic failure. Circulation 2000, 101:2710–2715. This work shows for the first time that sympathetic tone is sufficient to drive supine hypertension in patients with central autonomic failure due to multiple system atrophy. However, peripheral sympathetic neurons are disconnected from cortical and baroreflex input. Manipulation of peripheral sympathetic neurons could be used to treat orthostatic hypotension and supine hypertension.PubMedGoogle Scholar
  5. 5.
    Jordan J, Shannon JR, Grogan E, et al.: A potent pressor response elicited by drinking water. Lancet 1999, 353:723.PubMedCrossRefGoogle Scholar
  6. 6.
    Jordan J, Shannon JR, Black BK, et al.: The pressor response to water drinking in humans: a sympathetic reflex? Circulation 2000, 101:504–509. This work shows that water drinking elicits a pressor effect in a large group of autonomic failure patients. Water can be used to attenuate symptoms of orthostatic hypotension. The mechanisms of the pressor effect are discussed.PubMedGoogle Scholar
  7. 7.
    Sato T, Kawada T, Shishido T, et al.: Novel therapeutic strategy against central baroreflex failure: a bionic baroreflex system. Circulation 1999, 100:299–304. Groundbreaking studies in animals. The authors developed an artificial baroreflex system to treat central autonomic dysfunction in animals.PubMedGoogle Scholar
  8. 8.
    Jacob G, Ertl AC, Shannon JR, et al.: Effect of standing on neurohormonal responses and plasma volume in healthy subjects. J Appl Physiol 1998, 84:914–921.PubMedGoogle Scholar
  9. 9.
    Youmans JB, Wells HS, Donley D, Miller DG: The effect of posture (standing) on the serum protein concentration and colloid osmotic pressure of blood. J Clin Invest 1934, 13:447–459.PubMedGoogle Scholar
  10. 10.
    Jacobsen TN, Morgan BJ, Scherrer U, et al.: Relative contributions of cardiopulmonary and sinoaortic baroreflexes in causing sympathetic activation in the human skeletal muscle circulation during orthostatic stress. Circ Res 1993, 73:367–378.PubMedGoogle Scholar
  11. 11.
    Smit AA, Halliwill JR, Low PA, Wieling W: Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol Lond 1999, 519 Pt 1:1–10. Excellent overview on the mechanisms of orthostatic hypotension. This paper also gives an overview on the use of physical countermeasures in the treatment of orthostatic hypotension.PubMedCrossRefGoogle Scholar
  12. 12.
    Bradbury S, Eggleston C: Postural hypotension: a report of three cases. Am Heart J 1925, 1:73–86.CrossRefGoogle Scholar
  13. 13.
    Robertson D, Hollister AS, Biaggioni I, et al.: The diagnosis and treatment of baroreflex failure. N Engl J Med 1993, 329:1449–1455.PubMedCrossRefGoogle Scholar
  14. 14.
    Jordan J, Shannon JR, Black B, et al.: Malignant vagotonia due to selective baroreflex failure. Hypertension 1997, 30:1072–1077.PubMedGoogle Scholar
  15. 15.
    Wenning GK, Tison F, Ben SY, et al.: Multiple system atrophy: a review of 203 pathologically proven cases. Move Disord 1997, 12:133–147.CrossRefGoogle Scholar
  16. 16.
    Kanda T, Tomimitsu H, Yokota T, et al.: Unmyelinated nerve fibers in sural nerve in pure autonomic failure. Ann Neurol 1998, 43:267–271.PubMedCrossRefGoogle Scholar
  17. 17.
    Robertson D, Goldberg MR, Onrot J, et al.: Isolated failure of autonomic noradrenergic neurotransmission: evidence of impaired b-hydroxylation of dopamine. N Engl J Med 1986, 314:1494–1497.PubMedCrossRefGoogle Scholar
  18. 18.
    Gaan D, Mahoney MP, Rowlands DJ, Jones AW: Postural hypotension in amyloid disease. Am Heart J 1972, 84:395–400.PubMedCrossRefGoogle Scholar
  19. 19.
    Lagi A, Bacalli S, Cencetti S, et al.: Cerebral autoregulation in orthostatic hypotension. A transcranial Doppler study. Stroke 1994, 25:1771–1775.PubMedGoogle Scholar
  20. 20.
    Wilcox CS, Aminoff MJ, Penn W: Basis of nocturnal polyuria in patients with autonomic failure. J Neurol Neurosurg Psychiatry 1974, 37:677–684.PubMedGoogle Scholar
  21. 21.
    Jordan J, Shannon JR, Pohar B, et al.: Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol 1999, 10:35–42.PubMedGoogle Scholar
  22. 22.
    Kaufmann H, Oribe E, Pierotti AR, et al.: Atrial natriuretic factor in human autonomic failure. Neurology 1990, 40:1115–1119.PubMedGoogle Scholar
  23. 23.
    Wilcox CS, Aminoff MJ, Slater JD: Sodium homeostasis in patients with autonomic failure. Clin Sci Mol Med 1977, 53:321–328.PubMedGoogle Scholar
  24. 24.
    Robertson D, Kincaid DW, Haile V, Robertson RM: The head and neck discomfort of autonomic failure: an unrecognized aetiology of headache. Clin Autonom Res 1994, 4:99–103.CrossRefGoogle Scholar
  25. 25.
    Vagaonescu TD, Saadia D, Tuhrim S, et al.: Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 2000, 355:725–726.PubMedCrossRefGoogle Scholar
  26. 26.
    Jordan J, Shannon JR, Biaggioni I, et al.: Contrasting actions of pressor agents in severe autonomic failure. Am J Med 1998, 105:116–124. This study compares the acute effect of several commonly used pressor agents, such as phenylpropranolamine, yohimbine, indomethacin, ibuprofen, midodrine, methylphenidate, and caffeine.PubMedCrossRefGoogle Scholar
  27. 27.
    Masaki KH, Schatz I, Burchfield CM, et al.: Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation 1998, 98:2290–2295.PubMedGoogle Scholar
  28. 28.
    Fouad-Tarazi FM, Okabe M, Goren H: Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med 1995, 99:604–610.PubMedCrossRefGoogle Scholar
  29. 29.
    Low PA, Gilden JL, Freeman R, et al.: Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 1997, 277:1046–1051. Perhaps the only larger, placebo-controlled, double-blinded study on the treatment of orthostatic hypotension with 10 mg midodrine three times a day. Midodrine was shown to be effective in the treatment of orthostatic hypotension. In our opinion, the doses used in this study were quite high and can lead to dangerous elevations of blood pressure in patients with severe autonomic failure. We recommend ingesting the last dose of midodrine at noon or in the early afternoon to avoid supine hypertension during the night.PubMedCrossRefGoogle Scholar
  30. 30.
    Smit AA, Wieling W, Opfer GT, et al.: Patients’ choice of portable folding chairs to reduce symptoms of orthostatic hypotension. Clin Auton Res 1999, 9:341–344. This is truly patient-oriented research.PubMedCrossRefGoogle Scholar
  31. 31.
    Denq JC, Opfer GT, Giuliani M, et al.: Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res 1997, 7:321–326.PubMedCrossRefGoogle Scholar
  32. 32.
    Shear L: Orthostatic hypotension. Treatment with sodium chloride and sodium retaining steroid hormones. Arch Intern Med 1968, 122:467–471.PubMedCrossRefGoogle Scholar
  33. 33.
    Hickler RB, Thompson GR, Fox LM, Hamlin JT: Successful treatment of orthostatic hypotension with 9-alpha-fluorohydrocortisone. N Engl J Med 1959, 261:788–791.PubMedCrossRefGoogle Scholar
  34. 34.
    Davidson C, Smith D, Morgan DB: Diurnal pattern of water and electrolyte excretion and body weight in idiopathic orthostatic hypotension. The effect of three treatments. Am J Med 1976, 61:709–715.PubMedCrossRefGoogle Scholar
  35. 35.
    Mitsky VP, Workman RJ, Nicholson WE, et al.: A sensitive radioimmunoassay for fludrocortisone in human plasma. Steroids 1994, 59:555–558.PubMedCrossRefGoogle Scholar
  36. 36.
    Chobanian AV, Volicer L, Tifft CP, et al.: Mineralocorticoidinduced hypertension in patients with orthostatic hypotension. N Engl J Med 1979, 301:68–73.PubMedCrossRefGoogle Scholar
  37. 37.
    Bannister R, Ardill L, Fentem P: An assessment of various methods of treatment of idiopathic orthostatic hypotension. Q J Med 1969, 38:377–395.PubMedGoogle Scholar
  38. 38.
    Shannon JR, Jordan J, Costa F, et al.: The hypertension of autonomic failure and its treatment. Hypertension 1997, 30:1062–1067.PubMedGoogle Scholar
  39. 39.
    Biaggioni I, Onrot J, Stewart CK, Robertson D: The potent pressor effect of phenylpropanolamine in patients with autonomic impairment. JAMA 1987, 258:236–239.PubMedCrossRefGoogle Scholar
  40. 40.
    Robertson D, Hollister AS, Carey EL, et al.: Increased vascular beta2-adrenoreceptor responsiveness in autonomic dysfunction. J Am Coll Cardiol 1984, 3:850–856.PubMedCrossRefGoogle Scholar
  41. 41.
    Davies B, Sudera D, Sagnella G, et al.: Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man. J Clin Invest 1982, 69:779–784.PubMedCrossRefGoogle Scholar
  42. 42.
    Mohring J, Glanzer K, Maciel JJ, et al.: Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol 1980, 2:367–376.PubMedCrossRefGoogle Scholar
  43. 43.
    Page IH, McCubbin JW: Buffer reflexes, tolerance to ganglioplegics and their relationship to enhanced pressor responsiveness. Am J Physiol 1959, 197:217–222.PubMedGoogle Scholar
  44. 44.
    Haas E, Goldblatt H: Effects of various ganglionic blocking agents on blood pressure and on activity of pressor agents. J Physiol 1960, 198:1023–1028.Google Scholar
  45. 45.
    Shannon JR, Jordan J, Black B, et al.: Uncoupling of the baroreflex by NN-cholinergic blockade in dissecting the components of cardiovascular regulation. Hypertension 1998, 101–107.Google Scholar
  46. 46.
    Robertson D: Contraindication to the use of ocular phenylephrine in idiopathic orthostatic hypotension. Am J Ophthalmol 1979, 87:819–822.PubMedGoogle Scholar
  47. 47.
    Wilkinson GR, Beckett AH: Absorption, metabolism and excretion of the ephedrines in man. I. The influence of urinary pH and urine volume output. J Pharm Exp Ther 1968, 162:139–147.Google Scholar
  48. 48.
    Sever PS, Dring LG, Williams RT: The metabolism of (−)-ephedrine in man. Eur J Clin Pharmacol 1975, 9:193–198.PubMedCrossRefGoogle Scholar
  49. 49.
    FDA: Food Advisory Committee meeting. Clinical summaries of adverse event reports on dietary supplements that may contain ephedrine alkaloids. Docket No. 95N-0304; 1996:1–125.Google Scholar
  50. 50.
    Crook JE, Robertson D, Whorton AR: Prostaglandin suppression: inability to correct severe idiopathic orthostatic hypotension. South Med J 1981, 74:318–320.PubMedGoogle Scholar
  51. 51.
    Abate G, Polimeni RM, Cuccurullo F, et al.: Effects of indomethacin on postural hypotension in Parkinsonism. BMJ 1979, 2:1466–1468.PubMedCrossRefGoogle Scholar
  52. 52.
    Kochar MS, Itskovitz HD: Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin. Lancet 1978, 1:1011–1014.PubMedCrossRefGoogle Scholar
  53. 53.
    Goldberg MR, Robertson D, FitzGerald GA: Prostacyclin biosynthesis and platelet function in autonomic dysfunction. Neurology 1985, 35:120–123.PubMedGoogle Scholar
  54. 54.
    Davies IB, Bannister R, Hensby C, Sever PS: The pressor actions of noradrenaline and angiotension II in chronic autonomic failure treated with indomethacin. Br J Clin Pharmacol 1980, 10:223–229.PubMedGoogle Scholar
  55. 55.
    Onrot J, Goldberg MR, Biaggioni I, et al.: Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med 1985, 313:549–554.PubMedCrossRefGoogle Scholar
  56. 56.
    Onrot J, Goldberg MR, Biaggioni I, et al.: Oral yohimbine in human autonomic failure. Neurology 1987, 37:215–220.PubMedGoogle Scholar
  57. 57.
    Hoffman WE, Phillips MI, Wilson E, Schmid PG: A pressor response associated with drinking in rats. Proc Soc Exp Biol Med 1977, 154:121–124.PubMedGoogle Scholar

Copyright information

© Current Science Inc 2001

Authors and Affiliations

  • Jens Jordan
    • 1
  1. 1.Franz-Volhard-Clinic, Haus 129Humboldt UniversityBerlinGermany

Personalised recommendations